THE VIBE SCIENCE PODCAST
Dustin Robinson joins Ryan Alford to discuss the growing body of scientific research surrounding psychedelic medicine and why mental health innovation may be entering a new era. As an attorney, investor, and advocate for responsible legal reform, Dustin explains how compounds once dismissed by society are now being studied for PTSD, depression, anxiety, and neurodegenerative diseases. Ryan and Dustin explore FDA clinical trials, neuroplasticity, the importance of evidence-based medicine, and why responsible regulation is key to unlocking these therapies safely. They also discuss non-hallucinogenic psychedelics, Alzheimer’s research, virtual reality treatments, and how innovation could reshape the future of behavioral health. TOPICS COVERED * Psychedelic medicine research * PTSD and MDMA therapy * Depression and psilocybin * Neuroplasticity * Alzheimer’s and dementia * FDA clinical trials * Responsible legalization * Mental health innovation * Virtual reality therapeutics * Ryan Alford and Dustin Robinson on the future of behavioral health LINKS Dustin Robinson * Instagram: https://www.instagram.com/dustinr10/ * ETHER Investments: https://etherinvestments.com Ryan Alford * https://www.instagram.com/ryanalford/ * https://vibesciencepodcast.com
160 episodes
Comments
0Be the first to comment
Sign up now and become a member of the THE VIBE SCIENCE PODCAST community!